These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 28647208)
21. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC. Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555 [TBL] [Abstract][Full Text] [Related]
22. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer. Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752 [TBL] [Abstract][Full Text] [Related]
24. KK-LC-1 may be an effective prognostic biomarker for gastric cancer. Ji J; Chen J; Wang A; Zhang W; Ju H; Liu Y; Li L BMC Cancer; 2021 Mar; 21(1):267. PubMed ID: 33711953 [TBL] [Abstract][Full Text] [Related]
25. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma. Han L; Jiang B; Wu H; Zhang S; Lu X Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753 [TBL] [Abstract][Full Text] [Related]
26. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164 [TBL] [Abstract][Full Text] [Related]
27. The expression of MAGE-C1 and MAGE-C2 in breast cancer and their clinical significance. Hou S; Sang M; Zhao L; Hou R; Shan B Am J Surg; 2016 Jan; 211(1):142-51. PubMed ID: 26321295 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer. Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503 [TBL] [Abstract][Full Text] [Related]
29. Expression and significance of Musashi-1 in gastric cancer and precancerous lesions. Kuang RG; Kuang Y; Luo QF; Zhou CJ; Ji R; Wang JW World J Gastroenterol; 2013 Oct; 19(39):6637-44. PubMed ID: 24151393 [TBL] [Abstract][Full Text] [Related]
30. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance. Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278 [TBL] [Abstract][Full Text] [Related]
31. MAGE-D4B is a novel marker of poor prognosis and potential therapeutic target involved in breast cancer tumorigenesis. Germano S; Kennedy S; Rani S; Gleeson G; Clynes M; Doolan P; McDonnell S; Hughes L; Crown J; O'Driscoll L Int J Cancer; 2012 May; 130(9):1991-2002. PubMed ID: 21618523 [TBL] [Abstract][Full Text] [Related]
32. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival. Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744 [TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma. Zhou JX; Li Y; Chen SX; Deng AM J Exp Clin Cancer Res; 2011 Jan; 30(1):2. PubMed ID: 21211023 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer. Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644 [TBL] [Abstract][Full Text] [Related]
35. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer. Cheng Y; Yang B; Xi Y; Chen X Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161 [TBL] [Abstract][Full Text] [Related]
36. Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer. Zhao Q; Xu WT; Shalieer T Dis Markers; 2016; 2016():2325987. PubMed ID: 27843173 [No Abstract] [Full Text] [Related]
37. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
38. ADAM 10 is associated with gastric cancer progression and prognosis of patients. Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244 [TBL] [Abstract][Full Text] [Related]
39. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma. Brisam M; Rauthe S; Hartmann S; Linz C; Brands RC; Kübler AC; Rosenwald A; Müller-Richter UD Oncol Rep; 2016 Apr; 35(4):1979-86. PubMed ID: 26820613 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of MAGE-D4 in colorectal cancer is a potentially prognostic biomarker and immunotherapy target. Zhang QM; He SJ; Shen N; Luo B; Fan R; Fu J; Luo GR; Zhou SF; Xiao SW; Xie XX Int J Clin Exp Pathol; 2014; 7(7):3918-27. PubMed ID: 25120768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]